Merck and its insurers argue over adjustment of $1.3bn NotPetya claim


In the latest development in the high-profile dispute over Merck’s losses from 2017’s NotPetya cyber attack, insurers have hit back at the pharmaceutical giant’s argument that the court should treat its claim for more than $1.3bn as uncontested.

Want to read this article?

Subscribe for FULL access to this article - and ALL our premium content

For details on how to subscribe or for all commercial opportunities, including advertising, please contact:

Spencer Halladey
Commercial director
Tel: +44 (0) 203 934 6687

Andy Stone
Sales manager
Tel: +44 (0) 203 934 6684

Subscribers get access to:

  • Breaking news by email on all critical issues
  • Trusted analysis and commentary
  • Opinion from market thought-leaders
  • Exclusive data on the industry
  • Daily digital newsletter
  • Full access to our online archive


If you are a subscriber you can SIGN IN now for FULL access